Heart Failure: Clinical Trials

304 trials for Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

173 completed, 39 unknown, 27 recruiting, 26 terminated. 304 Phase 1, 113 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1304Completed 173, Unknown 39, Recruiting 27, Terminated 26, Withdrawn 21, Not yet recruiting 8, Active not recruiting 6, Suspended 3, Enrolling by invitation 1
Phase 2113Completed 55, Unknown 21, Terminated 10, Withdrawn 9, Recruiting 7, Active not recruiting 5, Not yet recruiting 5, Suspended 1

Follow Heart Failure: new trials by email Literature Review of Heart Failure trials Research Report on Heart Failure

Trials (filtered) newest first · largest first

All 304 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Relaxin Therapy for Atrial Fibrillation
Relaxin, Placebo - Atrial Fibrillation (AF), Arrhythmia
Phase 1 / Phase 2Not yet recruitingDeeptankar DeMazumder2082027-01-012026-01-22
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
Protek Solo Transseptal Cannula - Lung Transplant, Pulmonary Hypertension
Phase 1RecruitingMayo Clinic42026-12-112026-07-31
[11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction
[11C]PS13: [carbon-11]PS13; COX-1 PET radioligand, Sacubitril-Valsartan - Heart Failure With Reduced Ejection Fraction, Cognitive Impairment, Mild
Phase 1Not yet recruitingStony Brook University182026-10-012026-10-02
A Study of LY3971297 in Participants With Heart Failure
LY3971297, Placebo - Heart Failure, Heart Failure, Diastolic
Phase 1RecruitingEli Lilly and Company902026-08-112026-09-22
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
SGLT-2 inhibitor, SGLT2 inhibitor - Duchenne Muscular Dystrophy (DMD)
Phase 1RecruitingVanderbilt University Medical Center102026-07-012026-08-24
Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF
Henggliflozin Combined with Probiotics, Henggliflozin, double placebo - Heart Failure, Preserved Ejection Fraction
Phase 1 / Phase 2Not yet recruitingThe First Affiliated Hospital of Air Force Medicial University1622026-07-012026-07-07
A Study of Metformin to Improve Cardiac Function After LVAD Implantation
Metformin Hydrochloride, Placebo - Heart Failure, Left Ventricular Assist Device
Phase 1 / Phase 2RecruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1082026-07-012026-09-02
A Phase I Study of Allogeneic Myocardium-Derived Mesenchymal Stem Cells (HB1011) in Patients With Ischemic Cardiomyopathy
HB1011 (Allogeneic Myocardium-derived Mesenchymal Stem Cells) - Ischemic Cardiomyopathy
Phase 1RecruitingHieraBio Inc.122026-06-232026-10-06
A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants
CDR132L (i.v.), CDR132L (s.c.) - Healthy Volunteers, Heart Failure
Phase 1RecruitingNovo Nordisk A/S322026-06-172026-06-30
A Clinical Study of HRS-7156 in Healthy Participants
HRS-7156, HRS-7156 placebo - Heart Failure
Phase 1RecruitingShandong Suncadia Medicine Co., Ltd.662026-06-122026-08-24
A Clinical Study of HRS-5765 in Healthy Participants
HRS-5765 Tablet, HRS-5765 Tablet Placebo - Heart Failure
Phase 1RecruitingChengdu Suncadia Medicine Co., Ltd.742026-05-202026-05-26
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
FAP immunosuppressive CAR-DC - Dilated Cardiomyopathy (DCM), Heart Failure
Phase 1RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine52026-05-112026-07-02
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
RP-A701 is a recombinant viral vector composed of an AAV serotype rh.74 (AAVrh.74) capsid encapsulating the transgene, BCL2-associated Athanogene 3 (BAG3) - Dilated Cardiomyopathy (DCM)
Phase 1RecruitingRocket Pharmaceuticals Inc.82026-04-172026-10-01
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
HJB647 low dose, HJB647 high dose, Placebo - Heart Failure With Reduced Ejection Fraction
Phase 1RecruitingNovartis Pharmaceuticals122026-03-182026-10-01
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
HS-005 - Heart Failure, Ischemic Heart Failure
Phase 1 / Phase 2RecruitingHeartseed Inc.142026-01-192026-10-22
Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial
Vericiguat tablet, Sacubitril / Valsartan - Decompensated Heart Failure
Phase 1RecruitingKhawaja Danish Ali1302026-01-012026-03-02
The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)
Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#), conventional treatment - Heart Failure
Phase 1 / Phase 2SuspendedSclnow Biotechnology Co., Ltd.602025-12-312025-05-14
A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure
SHR-4658 Injection., SHR-4658 Placebo Injection - Heart Failure
Phase 1Not yet recruitingBeijing Suncadia Pharmaceuticals Co., Ltd482025-11-012025-11-17
A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure
NNC0537-1482, Placebo - Heart Failure
Phase 1RecruitingNovo Nordisk A/S362025-10-232026-09-01
Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure
MTP-101-C encapsulated Microbiota, Vancomycin, Neomycin - Chronic Heart Failure
Phase 1RecruitingMelana Yuzefpolskaya, MD402025-10-202026-10-08

Showing 20 of 304. Sign in to see all of them.

Narrower conditions

Cardiomyopathies (21)  ·  Cardiomyopathy, Dilated (16)  ·  Cardiovascular Diseases (16)  ·  Heart Diseases (12)  ·  Myocardial Infarction (12)  ·  Heart Failure, Systolic (11)  ·  Renal Insufficiency (11)  ·  Heart Failure, Diastolic (9)  ·  Coronary Artery Disease (8)  ·  Hypertension (8)  ·  Myocardial Ischemia (8)  ·  Mitral Valve Insufficiency (6)  ·  Pulmonary Disease, Chronic Obstructive (5)  ·  Breast Neoplasms (4)

Broader conditions

Heart Diseases (292)  ·  Cardiovascular Diseases (288)  ·  Pathological Conditions, Signs and Symptoms (56)  ·  Vascular Diseases (41)  ·  Pathologic Processes (40)  ·  Myocardial Ischemia (20)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (19)  ·  Female Urogenital Diseases (19)  ·  Female Urogenital Diseases and Pregnancy Complications (19)  ·  Male Urogenital Diseases (19)  ·  Urogenital Diseases (19)  ·  Urologic Diseases (19)  ·  Respiratory Tract Diseases (18)  ·  Genetic Diseases, Inborn (17)  ·  Kidney Diseases (17)

Interventions

Furosemide (8)  ·  Natriuretic Peptide, Brain (7)  ·  AZD9977 (6)  ·  Carvedilol (4)  ·  Saline Solution (4)  ·  Sodium Chloride (4)  ·  vericiguat (4)  ·  Coronary Artery Bypass (3)  ·  Interleukin 1 Receptor Antagonist Protein (3)  ·  Spironolactone (3)  ·  Triiodothyronine (3)  ·  cenderitide (3)  ·  dapagliflozin (3)  ·  empagliflozin (3)  ·  sacubitril and valsartan sodium hydrate drug combination (3)

Sponsors

Mayo Clinic (13)  ·  AstraZeneca (12)  ·  Bristol-Myers Squibb (10)  ·  Bayer (7)  ·  Yale University (6)  ·  GlaxoSmithKline (5)  ·  HELP Therapeutics Co., Ltd. (5)  ·  Imperial College London (4)  ·  University of Pennsylvania (4)  ·  Virginia Commonwealth University (4)  ·  Alleviant Medical, Inc. (3)  ·  Amgen (3)  ·  Bial - Portela C S.A. (3)  ·  Capricor Inc. (3)  ·  Cytokinetics (3)

Countries

United States (147)  ·  China (22)  ·  United Kingdom (21)  ·  Germany (20)  ·  Canada (11)  ·  Japan (9)  ·  Poland (9)  ·  Netherlands (7)  ·  Australia (5)  ·  Brazil (5)  ·  Czechia (5)  ·  Bulgaria (4)  ·  Denmark (4)  ·  India (4)  ·  Israel (4)

Top investigators

Horng H. Chen, M.D. (5)  ·  Jeffrey Testani, MD (4)  ·  Amit Patel, MD (3)  ·  Horng H Chen, MD (3)  ·  Andrew R Coggan, PhD (2)  ·  Anne R Cappola, MD,ScM (2)  ·  Barry Greenberg, MD (2)  ·  Bonnie Ky, MD, MSCE (2)  ·  Darrel P Francis, MD (2)  ·  Deborah Ascheim, MD (2)

Results publications

PMID 22936827, PMID 23031283, PMID 37804170, PMID 40899260, PMID 10618557, PMID 10723976, PMID 10843268, PMID 10999979, PMID 11176729, PMID 11561221, PMID 11705426, PMID 11755290, PMID 11832662, PMID 11911756, PMID 12016627, PMID 12140801, PMID 12140805, PMID 12151474, PMID 15704055, PMID 15739984, PMID 15795361, PMID 15812741, PMID 17874006, PMID 18553028, PMID 19293069, PMID 19327618, PMID 19679246, PMID 19933409, PMID 19958962, PMID 20386074, PMID 21422390, PMID 21492763, PMID 21709064, PMID 21794114, PMID 21856480, PMID 22088800, PMID 22438931, PMID 22651868, PMID 22965994, PMID 22968742, PMID 22980293, PMID 23099357, PMID 23122795, PMID 23362308, PMID 23592107, PMID 23633132, PMID 24065463, PMID 24107588, PMID 24444305, PMID 24627436

NIH funding

P01HL076611 (5), R01HL084155 (5), UL1RR024150 (4), 2014 (3), 2017 (3), R01DK130997 (3), 2005 (2), 2016 (2), 2019 (2), R61HL146390 (2), UL1TR000135 (2), 1KL2RR031989-01 (1), 2015 (1), 2023 (1), 2025 (1)